This dual agonism allows the drug to lower glucose levels and reduce weight, but the side effects reported for Mounjaro are similar to other GLP-1 agonists
The STEP trial program examining higher-dose semaglutide (2.4 mg weekly) for weight management demonstrated mean weight loss of 12% to 15% over 68 weeks in adults with obesity, significantly exceeding placebo
Bacteriostatic saline containing benzyl alcohol decreases pain associated with propofol injection
Semaglutide is a single-receptor GLP-1 agonist one of the most clinically studied weight-loss medications available, with an average 15% body weight reduction in trials
10 and shared on Reddit, Hers said, "As you are on a personalized dose, this announcement [of the end of the semaglutide shortage] does not directly impact your subscription, and your affiliated pharmacy will be sending your next prescription refill as scheduled." Users of other telehealth platforms received similar messages
When used as part of a complete weight loss regimen, semaglutide has been shown to reduce body weight by 16% in just four months